DYNAVAX TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 21 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-07-11: Reporting owner Janssen Robert; Form 3; Security Option (Right to Buy); Transaction Holding.
- 2013-07-11: Reporting owner Janssen Robert; Form 3; Security Option (Right to Buy); Transaction Holding.
- 2013-07-11: Reporting owner Janssen Robert; Form 3; Security Option (Right to Buy); Transaction Holding.
- 2013-07-11: Reporting owner Janssen Robert; Form 3; Security Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-07-11 holding as of filing | Janssen Robert Officer (Chief Medical Officer and VP) | 3 | Option (Right to Buy) Derivative · Direct | Holding | $1.36 exercise price | 2013-07-11 | ||
| 2013-07-11 holding as of filing | Janssen Robert Officer (Chief Medical Officer and VP) | 3 | Option (Right to Buy) Derivative · Direct | Holding | $3.14 exercise price | 2013-07-11 | ||
| 2013-07-11 holding as of filing | Janssen Robert Officer (Chief Medical Officer and VP) | 3 | Option (Right to Buy) Derivative · Direct | Holding | $3.68 exercise price | 2013-07-11 | ||
| 2013-07-11 holding as of filing | Janssen Robert Officer (Chief Medical Officer and VP) | 3 | Option (Right to Buy) Derivative · Direct | Holding | $4.14 exercise price | 2013-07-11 | ||
| 2013-07-03 | RICCIARDI NATALE S Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.06 exercise price | 2013-07-08 | |
| 2013-05-29 | ORONSKY ARNOLD L Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $2.55 exercise price | 2013-06-05 | |
| 2013-05-29 | CANO FRANCIS Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $2.55 exercise price | 2013-06-05 | |
| 2013-05-29 | CARSON DENNIS Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $2.55 exercise price | 2013-06-05 | |
| 2013-05-29 | GILBERT DENISE Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $2.55 exercise price | 2013-06-05 | |
| 2013-05-29 | KISNER DANIEL L Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $2.55 exercise price | 2013-06-05 | |
| 2013-05-29 | Phillips Peggy V Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $2.55 exercise price | 2013-06-05 | |
| 2013-05-29 | Plotkin Stanley A Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $2.55 exercise price | 2013-06-05 | |
| 2013-05-29 | DINA DINO Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $2.55 exercise price | 2013-06-05 | |
| 2013-05-01 | DINA DINO Director | 4 | Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $2.21 exercise price | 2013-05-03 | |
| 2013-05-01 | Gray Eddie Director, Officer (CEO and Director) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500,000 1,500,000 owned after | $2.21 exercise price | 2013-05-03 | |
| 2013-03-25 | Novack David F Officer (Senior Vice President) | 4 | Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $2.14 exercise price | 2013-03-27 | |
| 2013-02-05 | COFFMAN ROBERT Officer (Chief Scientific Officer & VP) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −180,000 180,000 owned after | $3.08 exercise price | 2013-02-07 | |
| 2013-02-05 | Lew Jennifer Officer (VP, Finance & PAO) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −150,000 150,000 owned after | $3.08 exercise price | 2013-02-07 | |
| 2013-02-05 | OSTRACH MICHAEL S Officer (VP, CBO, and General Counsel) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −200,000 200,000 owned after | $3.08 exercise price | 2013-02-07 | |
| 2013-02-05 | TUCK STEPHEN F Officer (VP, Global Technical Ops) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −200,000 200,000 owned after | $3.08 exercise price | 2013-02-07 | |
| 2013-01-15 | TUCK STEPHEN F Officer (VP, Global Technical Ops) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 50,000 owned after | $1.50 exercise price | 2013-01-17 |